Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice

Hepatology

Volumn 42, Issue 2, 2005, Pages 400-410

  Wang, Xiaodong ^a   Lu, Yongke ^a   Cederbaum, Arthur I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ALANINE AMINOTRANSFERASE; ALCOHOL; CARBONYL DERIVATIVE; CASPASE 3; CASPASE 8; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME P450 2E1; DNA FRAGMENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FAS ANTIBODY; FAS ANTIGEN; GLUTATHIONE; JO2 ANTIBODY; MALONALDEHYDE; PROTEIN CARBONYL; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HISTOPATHOLOGY; IN VIVO STUDY; LIVER INJURY; LIVER TOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD95; ANTIOXIDANTS; APOPTOSIS; CATALYSIS; CHLORMETHIAZOLE; CYTOCHROME P-450 CYP2E1; ENZYME INDUCTION; LIPID PEROXIDATION; LIVER; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PYRAZOLES;

EID: 23044516645     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20792     Document Type: Article

References (50)

1. Baptista A, Bianchi L, De Groote J, Besmet VJ, Gedigk P, Korb G, et al. Alcoholic liver disease: morphological manifestation. Lancet 1981;28:707-711.
2. Rao RK, Seth A, Sheth P. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004;286:G881-G884.
3. Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P-450 HE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991;4:168-179.
4. Novak RF, Woodcroft KJ. The alcohol-inducible form of cytochrome P450 (CYP2E1): role in toxicology and regulation of expression. Arch Pharm Res 2000;23:267-282.
5. Gonzalez FJ. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat Res 2005;569:101-110.
6. Koop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 1992;6:724-730.
7. Yang CS, Yoo JSH, Ishizaki H, Hong J. Cytochrome P450 E1: roles in nitrosamine metabolism and mechanism of regulation. Drug Metab Rev 1990;22:147-159.
8. Morimoto M, Zern MA, Hagbjork AL, Ingelman-Sundberg M, French SW. Fish oil, alcohol, and liver pathology: role of cytochrome P450 2E1. Proc Soc Exp Biol Med 1994;207:197-205.
9. Nanji AA, Zhao S, Sadrzadeh SM, Dannenberg AJ, Tahan SR, Waxman DJ. Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcohol Clin Exp Res 1994;18:1280-1285.
10. Kurose I, Higuchi H, Miura S, Saito H, Watanabe N, Hokari R, et al. Oxidative stress mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. HEPATOLOGY 1997;25:368-378.
11. Deaciuc IV, Nikolova-Karakashian M, Fortunate F, Lee EY, Hill DB, McClain CJ. Apoptosis and dysregulated ceramide metabolism in a murine model of alcohol-enhanced lipopolysaccharide hepatotoxiciry. Alcohol Clin Exp Res 2000;24:1557-1565.
12. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-1456.
13. Cai J, Yang J, Jones DP. Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta 1998;1366:139-149.
14. Zhou Z, Sun X, Kang YJ. Ethanol-induced apoptosis in mouse liver: Fas- and cytochrome c-mediated caspase-3 activation pathway. Am J Pathol 2001;159:329-338.
15. Minana JB, Gomez-Cambronero L, Lloret A, Pallardo FV, Del Olmo J, Escudero A, et al. Mitochondrial oxidative stress and CD95 ligand: a dual mechanism for hepatocyte apoptosis in chronic alcoholism. HEPATOLOGY 2002;35:1205-1214.
16. Sosa L, Vidlak D, Strachota JM, Pavlik J, Jerrells TR. Rescue of in vivo FAS-induced apoptosis of hepatocytes by corticosteroids either associated with alcohol consumption by mice or provided exogenously. Int Immunopharmacol 2005;5:301-314.
17. Deaciuc IV, Fortunato F, D'Souza NB, Hill DB, Schmidt J, Lee EY, et al. Modulation of caspase-3 activity and Fas ligand mRNA expression in rat liver cells in vivo by alcohol and lipopolysaccharide. Alcohol Clin Exp Res 1999;23:349-356.
18. Castaneda F, Kinne RK. Apoptosis induced in HepG2 cells by short exposure to millimolar concentrations of ethanol involves the Fas-receptor pathway. J Cancer Res Clin Oncol 2001;127:418-424.
19. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. HEPATOLOGY 1998;27:128-133.
20. Tinel M, Berson A, Vadrot N, Descatoire V, Grodet A, Feldmann G, et al. Subliminal Fas stimulation increases the hepatotoxicity of acetaminophen and bromobenzene in mice. HEPATOLOGY 2004;39:655-666.
21. Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, Gores GJ. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J Hepatol 2003;39:978-983.
22. Reinke LA, Moyer MJ. P-nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos 1985;13: 548-552.
23. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407-421.
24. Chang B, Nishikawa M, Sato E, Inoue M. Mice lacking inducible nitric oxide synthase show strong resistance to anti-Fas antibody-induced fulminant hepatitis. Arch Biochem Biophys 2003;411:63-72.
25. Claiborne A, Fridovich I. Purification of the o-dianisidine peroxidase from Escherichia coli B. Physicochemical characterization and analysis of its dual catalatic and peroxidatic activities. J Biol Chem 1979;254:4245-4252.
26. Lee HC, Jung SA, Jung HK, Yi SY, Kim DY, Moon IH, et al. Protective effect of chlormethiazole, a sedative, against acetaminophen-induced liver injury in mice. Korean J Intern Med 1999;14:27-33.
27. Clemens MG. Nitric oxide in liver injury. HEPATOLOGY 1999;30:1-5.
28. McKim SE, Gabele E, Isayama F, Lambert JC, Tucker LM, Wheeler MD, et al. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 2003;125:1834-1844.
29. Gouillon Z, Lucas D, Li J, Hagbjork AL, French BA, Fu P, et al. Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med 2000;224:302-308.
30. Caro AA, Cederbaum AI. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 2004;44:27-42.
31. Kanzler S, Galle PR. Apoptosis and the liver. Semin Cancer Biol 2000;10: 173-184.
32. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al. Involvement of the CD95(APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230.
33. Bursh W, Oberhammer F, Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 1992;13:245-251.
34. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligation mouse: a link between apoptosis and fibrosis. Gastroenterology 2002;123:1323-1330.
35. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
36. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997;16:2794-2804.
37. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et. al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230.
38. Kakinuma C, Takagaki K, Yatomi T, Nakamura N, Nagata S, Uemura A, et al. Acute toxicity of an anti-Fas antibody in mice. Toxicol Pathol 1999; 27:412-420.
39. Pastorino JG, Shulga N, Hoek JB. TNF-alpha-induced cell death in ethanol-exposed cells depends on p38 MAPK signaling but is independent of Bid and caspase-8. Am J Physiol Gastrointest Liver Physiol 2003;285: G503-G516.
40. Pastorino JG, Hoek JB. Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition. HEPATOLOGY 2000;31:1141-1152.
41. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-809.
42. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000;105:1067-1075.
43. Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 1996;271: 12063-12067.
44. Kamimura S, Gaal K, Britton RS, Bacon BR, Triadafilopoulos G, Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. HEPATOLOGY 1992;16:448-453.
45. Rouach H, Fataccioli V, Gentil M, French SW, Morimoto M, Nordmann R. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. HEPATOLOGY 1997;25:351-355.
46. Zedda M, Lepore G, Gadau S, Manca P, Farina V. Morphological and functional changes induced by the amino acid analogue 3-nitrotyrosine in mouse neuroblastoma and rat glioma cell lines. Neurosci Lett 2004;363: 190-193.
47. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996;9:836-844.
48. Eiserich JP, Estevez AG, Bamberg TV, Ye YZ, Chumley PH, Beckman JS, et al. Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: a nitric oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci U S A 1999;96:6365-6370.
49. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424-C1437.
50. Gebhardt AC, Lucas D, Menez JF, Seitz HK. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans. HEPATOLOGY 1997;26:957-961.